All patients | TG/HDL-C tertile 1 (0.35–1.60) n = 64 | TG/HDL-C tertile 2 (1.61–3.00) n = 65 | TG/HDL-C tertile 3 (3.01–64.05) n = 64 | P value | |
---|---|---|---|---|---|
Age, years | 60 (50–69) | 59 (51–68) | 61 (51–70) | 57 (49–65) | 0.3249 |
Female sex, % | 26.8 | 28.2 | 28.2 | 24.1 | 0.7819 |
DM, % | 32.3 | 28.2 | 31.8 | 36.8 | 0.4837 |
Dialysis vintage, years | 9.4 (4.7–15.8) | 11.1 (5.7–16.3) | 10.8 (4.4–16.9) | 8.0 (4.6–13.8) | 0.2608 |
History of hypertension, % | 79.7 | 80.0 | 76.5 | 82.6 | 0.6107 |
History of previous CVD, % | 29.2 | 23.5 | 35.3 | 28.7 | 0.2394 |
Systolic BP, mmHg | 153 (139–165) | 154 (142–165) | 152 (138–166) | 153 (136–163) | 0.7112 |
Diastolic BP, mmHg | 82 (73–91) | 83 (76–91) | 81 (72–90) | 82 (70–93) | 0.4152 |
BMI, kg/m2 | 21.8 (19.7–24.4) | 20.5 (19.0–22.6) | 21.8 (19.7–24.0) | 23.2 (21.1–25.7) | <0.0001 |
Laboratory data | |||||
Hemoglobin, g/dL | 10.7 (10.2–11.2) | 10.7 (10.2–11.1) | 10.6 (10.1–11.2) | 10.8 (10.1–11.4) | 0.2499 |
Creatinine, mg/dL | 11.8 (10.3–13.5) | 11.4 (10.15–12.75) | 12.0 (10.15–13.65) | 12.3 (10.4–13.9) | 0.1032 |
Calcium (Ca), mg/dL; corrected | 9.0 (8.6–9.4) | 9.0 (8.6–9.4) | 9.1 (8.45–9.4) | 9.0 (8.6–9.4) | 0.9831 |
Phosphorus (P), mg/dL | 5.4 (4.6–6.1) | 5.5 (4.8–6.2) | 5.1 (4.4–5.9) | 5.5 (4.5–6.1) | 0.0967 |
Ca x P, (mg/dL)2 | 48.1 (40.9–55.2) | 51.4 (42.1–55.7) | 45.6 (40–54.1) | 47.8 (41.2–57) | 0.0554 |
Whole PTH, pg/mL | 63 (31–103) | 68 (28–95) | 53 (27–110) | 64 (34–114) | 0.5728 |
CRP, mg/L | 0.1 (0.1–0.3) | 0.1 (0.1–0.2) | 0.1 (0.1–0.3) | 0.1 (0.1–0.4) | 0.1403 |
Albumin, g/L | 3.9 (3.7–4.1) | 3.9 (3.7–4.1) | 3.9 (3.7–4.1) | 3.9 (3.7–4.1) | 0.9530 |
T-CHO, mg/dL | 157 (137–178) | 156 (136–177) | 150 (133–170) | 162 (142–188) | 0.0341 |
TG, mg/dL | 98 (70–144) | 60 (47–73) | 98 (83–112) | 172 (138–229) | <0.0001 |
HDL-C, md/dL | 44 (37–55) | 59 (51–72) | 43 (40–49) | 37 (31–41) | <0.0001 |
LDL-C, mg/dL | 77 (62–94) | 69 (54–86) | 79 (65–103) | 86 (64–105) | 0.0001 |
TG/HDL-C ratio | 2.28 (1.29–3.66) | 1.03 (0.76–1.29) | 2.27 (1.84–2.61) | 4.63 (3.62–6.57) | <0.0001 |
Medications, % | |||||
ESA | 92.5 | 91.5 | 90.5 | 95.4 | 0.4447 |
HMG-CoA reductase inhibitors | 29.4 | 22.9 | 24.7 | 40.5 | 0.0228 |
Antihypertensive agents | 79.0 | 77.7 | 78.8 | 80.5 | 0.9017 |